Home / Brand archive
5 reported ongoing
33 records in this archive. Latest source date Apr 22, 2025.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
cGMP Deviations
Class IIReported terminated
Distribution: RemedyRepack distributed product to consignees nationwide within the United States
cGMP Deviations
Class IIReported terminated
Distribution: RemedyRepack distributed product to consignees nationwide within the United States
cGMP Deviations
Class IIReported terminated
Distribution: RemedyRepack distributed product to consignees nationwide within the United States
cGMP Deviations
Class IIReported terminated
Distribution: RemedyRepack distributed product to consignees nationwide within the United States
Failed Impurities/Degradation specifications
Class IIReported terminated
Distribution: Product was distributed to one account in PA.
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Class IIReported terminated
Distribution: Product was distributed to two different customers in MI.
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Class IIReported terminated
Distribution: Distributed to two direct accounts in PA and AK.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIReported terminated
Distribution: Recalled product was distributed to Florida.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class IIReported terminated
Distribution: Product was distributed to FL, SC and VA
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class IIReported terminated
Distribution: Product was distributed to FL, SC and VA
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class IIReported terminated
Distribution: Product was distributed to customers in AK and PA.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Class IIReported terminated
Distribution: Product was distributed to one direct account in PA.
Failed Impurities/Degradation Specifications
Class IIReported terminated
Distribution: Product was distributed to two direct accounts in MI and PA.
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 33 records, including 5 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.